SCHEMBL28066296

SCHEMBL28066296

CCOC(=O)c1ccc(Oc2ccccc2OC)c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.57
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
TP53 P04637 1/20 0.50
HPGDS O60760 1/20 0.50
TSHR P16473 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
PLK1 P53350 1/20 0.48
HTT P42858 1/20 0.48
CYP3A4 P08684 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP2C19 P33261 1/20 0.47
GAA P10253 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 1/20 0.46
STAT6 P42226 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28066294 0.85 TSHR (0.49) CDC25BLMNAMAPTTSHRKMT2A
SCHEMBL29671336 0.82 TSHR (0.73) CDC25BMAPTTSHRMEN1KMT2A
SCHEMBL2569253 0.82 TSHR (0.73) CDC25BMAPTTSHRMEN1KMT2A
SCHEMBL28066258 0.81 HTT (0.68) CDC25BLMNAMAPTHPGDSKMT2A
SCHEMBL28854104 0.80 TSHR (0.49) CDC25BLMNAMAPTTP53TSHR
SCHEMBL1955830 0.80 KDM4E (0.49) CDC25BLMNAMAPTTSHRMEN1
SCHEMBL27793154 0.79 CDC25B (0.52) CDC25BLMNAMAPTTP53HPGDS
SCHEMBL4502266 0.77 TTR (0.53) LMNAMAPTTSHRHTTCYP3A4
SCHEMBL27822304 0.77 TSHR (0.53) CDC25BMAPTTSHRMEN1KMT2A
SCHEMBL27822305 0.77 TSHR (0.53) CDC25BTSHRMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105473548-A Amide derivatives as lysophosphatidic acid receptor antagonists TAKEDA PHARMACEUTICALS CO 2016-04-06 CN disclosed